Future Cow
Future Cow is an innovative startup in Brazil that specializes in cellular agriculture. Their groundbreaking technology produces dairy milk that is identical to cow milk, but without any cows being involved. Instead, they use advanced fermentation techniques to replicate the molecular proteins found in cow milk using a digitized copy of the cow gene, without taking any animal cells. This animal-free milk has far less of an environmental impact than traditional dairy, and it also addresses concerns around animal welfare. Additionally, this technology has the potential to disrupt the dairy industry by offering consumers a more ethical, sustainable, and delicious alternative to traditional dairy. Overall, Future Cow is excited to be at the intersection of science and food, developing technology that has the potential to change the way we think about dairy products.
Future Cow is an innovative startup in Brazil that specializes in cellular agriculture. Their groundbreaking technology produces dairy milk that is identical to cow milk, but without any cows being involved. Instead, they use advanced fermentation techniques to replicate the molecular proteins found in cow milk using a digitized copy of the cow gene, without taking any animal cells. This animal-free milk has far less of an environmental impact than traditional dairy, and it also addresses concerns around animal welfare. Additionally, this technology has the potential to disrupt the dairy industry by offering consumers a more ethical, sustainable, and delicious alternative to traditional dairy. Overall, Future Cow is excited to be at the intersection of science and food, developing technology that has the potential to change the way we think about dairy products.
Future Cow has raised $200k across 1 round. Its most recent round was a Pre-Seed of $200k in May 2023. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Future Cow is featured in
Similar companies
Cycles Nutrition offers evidence-based nutritional solutions that help individuals who care about their health improve their longevity and overall quality of life.
AIPER creates environmentally friendly pigments from agricultural waste using fermentation for the textile and cosmetics sectors. It suggests making biodegradable pigments from microbes as a sustainable option to harmful chemicals used in the industry, which helps clients reduce negative effects on water sources and the environment.
MinusSugar uses biotechnology to remove sugars from beverages, creating healthier options without changing taste or quality.
Decoy Smart Control is biological solutions developer for pest control.
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery & therapeutics.
AI Metrics is an early stage company creating transformational image analysis technology that positions radiologists to be the most efficient, valuable clinicians in the patient care continuum
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.
Hermes Biosciences describes a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes quickly, efficiently.
InvenireX is a biotech company that provides molecular diagnostics services.
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived from the Technical University of Denmark, this Danish biotech spin-out has established a biotech framework that employs fungi to generate exceptional and eco-friendly colorants.
Artios is an independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programs, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.
Bambusa Therapeutics is a biotechnology company that specializes in the development of bispecific antibodies.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.